Satsuma Pharmaceuticals EPS - Earnings per Share 2020-2023 | STSA
Satsuma Pharmaceuticals eps - earnings per share from 2020 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Satsuma Pharmaceuticals Annual EPS |
| 2022 |
$-2.19 |
| 2021 |
$-1.75 |
| 2020 |
$-2.73 |
| 2019 |
$-4.80 |
| 2018 |
$-7.15 |
| 2017 |
$-9.26 |
| Satsuma Pharmaceuticals Quarterly EPS |
| 2023-03-31 |
$-0.31 |
| 2022-12-31 |
$-0.70 |
| 2022-09-30 |
$-0.48 |
| 2022-06-30 |
$-0.52 |
| 2022-03-31 |
$-0.49 |
| 2021-12-31 |
$-0.47 |
| 2021-09-30 |
$-0.42 |
| 2021-06-30 |
$-0.38 |
| 2021-03-31 |
$-0.48 |
| 2020-12-31 |
$-0.71 |
| 2020-09-30 |
$-0.69 |
| 2020-06-30 |
$-0.65 |
| 2020-03-31 |
$-0.68 |
| 2019-12-31 |
$5.45 |
| 2019-09-30 |
$-2.26 |
| 2019-06-30 |
$-5.48 |
| 2019-03-31 |
$-2.51 |
